Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Skaar

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Journal of Medical Economics|June 8, 2022
Budget impact analysis of belumosudil for chronic graft-versus-host disease treatment in the United StatesCarlos R Bachier, Jeffrey R Skaar, Sumudu Dehipawala, et al.
BMC Nephrology|October 16, 2025
Real-world burden of primary hyperoxaluria with chronic kidney disease in the United States: a retrospective administrative claims analysisDavid S Goldfarb, Frank Modersitzki, Jeffrey R Skaar, et al.
Journal of Managed Care & Specialty Pharmacy|February 24, 2022
Clinical and economic impact of primary hyperoxaluria: a retrospective claims analysisLisa Mucha, Bernd Hoppe, Abigail Silber, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 10, 1982
[Ultrasonically guided puncture]T Larssen, K Hvidsten, R Skaar, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 9, 2003
Targeted disruption of p185/Cul7 gene results in abnormal vascular morphogenesisTakehiro Arai, Jocelyn S Kasper, Jeffrey R Skaar, et al.
Epilepsia Open|March 2, 2026
What does it mean to live with epilepsy? Burden of illness from the patient perspectiveJoanne M Wagner, Bhagyashree Oak, Brittany Smith, et al.
Molecular Cell|October 25, 2011
mTOR generates an auto-amplification loop by triggering the βTrCP- and CK1α-dependent degradation of DEPTORShanshan Duan, Jeffrey R Skaar, Shafi Kuchay, et al.
Journal of Medical Economics|March 16, 2024
Quantifying preferences for urea cycle disorder treatments using a discrete choice experimentJosiah Edelblut, Jeffrey R Skaar, John Hilton, et al.
American Heart Journal|April 5, 2026
Economic Burden Associated with Systemic Inflammation in Patients with HFmrEF/HFpEFTaiwo P Adesoba, Jeffrey R Skaar, Ashley Goss, et al.
International Journal of Cancer|November 15, 1996
Evidence for the involvement of ecto-5'-nucleotidase (CD73) in drug resistanceP Ujházy, E S Berleth, J M Pietkiewicz, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Journal of Medical Economics|June 8, 2022
Budget impact analysis of belumosudil for chronic graft-versus-host disease treatment in the United StatesCarlos R Bachier, Jeffrey R Skaar, Sumudu Dehipawala, et al.
BMC Nephrology|October 16, 2025
Real-world burden of primary hyperoxaluria with chronic kidney disease in the United States: a retrospective administrative claims analysisDavid S Goldfarb, Frank Modersitzki, Jeffrey R Skaar, et al.
Journal of Managed Care & Specialty Pharmacy|February 24, 2022
Clinical and economic impact of primary hyperoxaluria: a retrospective claims analysisLisa Mucha, Bernd Hoppe, Abigail Silber, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 10, 1982
[Ultrasonically guided puncture]T Larssen, K Hvidsten, R Skaar, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 9, 2003
Targeted disruption of p185/Cul7 gene results in abnormal vascular morphogenesisTakehiro Arai, Jocelyn S Kasper, Jeffrey R Skaar, et al.
Epilepsia Open|March 2, 2026
What does it mean to live with epilepsy? Burden of illness from the patient perspectiveJoanne M Wagner, Bhagyashree Oak, Brittany Smith, et al.
Molecular Cell|October 25, 2011
mTOR generates an auto-amplification loop by triggering the βTrCP- and CK1α-dependent degradation of DEPTORShanshan Duan, Jeffrey R Skaar, Shafi Kuchay, et al.
Journal of Medical Economics|March 16, 2024
Quantifying preferences for urea cycle disorder treatments using a discrete choice experimentJosiah Edelblut, Jeffrey R Skaar, John Hilton, et al.
American Heart Journal|April 5, 2026
Economic Burden Associated with Systemic Inflammation in Patients with HFmrEF/HFpEFTaiwo P Adesoba, Jeffrey R Skaar, Ashley Goss, et al.
International Journal of Cancer|November 15, 1996
Evidence for the involvement of ecto-5'-nucleotidase (CD73) in drug resistanceP Ujházy, E S Berleth, J M Pietkiewicz, et al.
Pageof 5